BioMarin Pharmaceutical, Inc. (BMRN)
55.95
-0.68
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
55.96
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Price : 55.95 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 56.68 | 56.81 | 55.24 | 55.95 | 1.683M |
| Oct 22, 2026 | 55.40 | 56.91 | 55.02 | 56.63 | 2.397M |
| Oct 21, 2026 | 56.40 | 57.00 | 54.91 | 55.21 | 2.506M |
| Oct 20, 2026 | 55.08 | 56.48 | 54.95 | 56.44 | 3.475M |
| Oct 19, 2026 | 54.78 | 55.12 | 54.08 | 54.67 | 2.996M |
| Oct 16, 2026 | 56.32 | 56.53 | 54.44 | 54.68 | 2.628M |
| Oct 15, 2026 | 56.45 | 57.59 | 55.96 | 56.05 | 2.923M |
| Oct 14, 2026 | 54.75 | 55.56 | 54.46 | 55.14 | 1.846M |
| Oct 13, 2026 | 55.30 | 55.66 | 53.93 | 54.38 | 2.662M |
| Oct 12, 2026 | 55.56 | 55.96 | 54.90 | 55.39 | 2.365M |
| Oct 09, 2026 | 54.80 | 55.98 | 54.48 | 54.80 | 2.146M |
| Oct 08, 2026 | 54.95 | 54.97 | 53.90 | 54.89 | 3.099M |
| Oct 07, 2026 | 56.05 | 56.60 | 54.76 | 55.20 | 2.079M |
| Oct 06, 2026 | 57.54 | 57.88 | 55.76 | 56.22 | 3.719M |
| Oct 05, 2026 | 57.11 | 58.11 | 56.82 | 57.54 | 2.408M |
| Oct 02, 2026 | 58.52 | 58.73 | 57.15 | 57.18 | 2.193M |
| Oct 01, 2026 | 59.81 | 60.16 | 58.39 | 58.44 | 2.083M |
| Sep 30, 2026 | 59.90 | 60.70 | 59.37 | 60.00 | 1.798M |
| Sep 29, 2026 | 59.24 | 60.09 | 58.96 | 59.87 | 1.808M |
| Sep 28, 2026 | 59.87 | 60.07 | 58.74 | 59.46 | 2.358M |
| Sep 25, 2026 | 61.50 | 61.50 | 60.17 | 60.26 | 1.791M |
| Sep 24, 2026 | 62.21 | 62.33 | 61.12 | 61.35 | 1.659M |
| Sep 23, 2026 | 63.68 | 64.00 | 61.58 | 62.21 | 2.105M |
| Sep 22, 2026 | 64.34 | 64.79 | 63.35 | 63.37 | 1.963M |
| Sep 21, 2026 | 64.35 | 64.96 | 63.58 | 64.06 | 1.877M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 243.37 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Cytokinetics, Inc. | 61.23 |
Price Related Metrics
| PE Ratio | 150.85 |
| PS Ratio | 3.142 |
| Price to Book Value | 1.713 |
| Price to Free Cash Flow | 14.98 |
| Earnings Yield | 0.66% |
| Market Cap | 10.83B |
| Operating PE Ratio | 16.98 |
| Normalized PE Ratio | 28.40 |